# Weekly Topotecan Therapy in Patients With Ovarian Cancer

> **NCT00194935** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 32 (—)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT00194935
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 32 (—)
- **Last updated:** 2006-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194935, "Weekly Topotecan Therapy in Patients With Ovarian Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00194935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*